Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain training may ease anxiety and boost memory in seniors

NCT ID NCT06063265

Symptom relief Sponsor: Hong Kong Baptist University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a 6-week Integrated Attention Training Program (IATP) in 120 older adults aged 60-90 who had both anxiety symptoms and subjective memory complaints. Participants were randomly assigned to either the attention training or a health education control group. The goal was to see if the training improved cognitive functions like attention and executive function, reduced anxiety, and lowered inflammation markers. Results are not yet available.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Integrated Attention Training Program (behavioural intervention)
What this could lead to
If it works, this could offer a non-drug way to help older adults with anxiety and memory concerns think more clearly and feel less anxious.
What could go wrong
This is a small, early-stage trial with no blinding for participants, and the benefits may not last beyond the 6-week program or apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Jul 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 90 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Older adults aged 60 to 90 years; 2. No Major Neurocognitive Disorders 3. Presence of anxiety symptoms 4. Presence of Subjective Cognitive Complaints Exclusion Criteria: 1. Clinical dementia 2. History of major depression 3. Presence of major neurological deficit 4. Presence of severe visual impairment; or 5. Currently on any psychotropic or other medications known to affect cognition; or 6. Participation in other cognitive trainings or interventions 6 months prior to this study or during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder subjective cognitive decline

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety

Contacts and locations

Locations

  • Ada WT FUNG

    Hong Kong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.